276 related articles for article (PubMed ID: 19768730)
1. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
3. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
[TBL] [Abstract][Full Text] [Related]
4. Visual rating of white matter hyperintensities in Parkinson's disease.
Beyer MK; Aarsland D; Greve OJ; Larsen JP
Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
[TBL] [Abstract][Full Text] [Related]
5. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
[TBL] [Abstract][Full Text] [Related]
6. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
[TBL] [Abstract][Full Text] [Related]
7. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.
Camicioli R; Gee M; Bouchard TP; Fisher NJ; Hanstock CC; Emery DJ; Martin WR
Parkinsonism Relat Disord; 2009 Mar; 15(3):187-95. PubMed ID: 18573676
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
9. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
[TBL] [Abstract][Full Text] [Related]
10. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
[TBL] [Abstract][Full Text] [Related]
11. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample.
Kumar R; Anstey KJ; Cherbuin N; Wen W; Sachdev PS
Am J Geriatr Psychiatry; 2008 Dec; 16(12):989-98. PubMed ID: 19038898
[TBL] [Abstract][Full Text] [Related]
12. Education, atrophy, and cognitive change in an epidemiological sample in early old age.
Christensen H; Batterham PJ; Mackinnon AJ; Anstey KJ; Wen W; Sachdev PS
Am J Geriatr Psychiatry; 2009 Mar; 17(3):218-26. PubMed ID: 19454848
[TBL] [Abstract][Full Text] [Related]
13. Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
Dalaker TO; Zivadinov R; Ramasamy DP; Beyer MK; Alves G; Bronnick KS; Tysnes OB; Aarsland D; Larsen JP
Mov Disord; 2011 Feb; 26(2):297-301. PubMed ID: 21412836
[TBL] [Abstract][Full Text] [Related]
14. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
[TBL] [Abstract][Full Text] [Related]
16. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
[TBL] [Abstract][Full Text] [Related]
17. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.
Duering M; Zieren N; Hervé D; Jouvent E; Reyes S; Peters N; Pachai C; Opherk C; Chabriat H; Dichgans M
Brain; 2011 Aug; 134(Pt 8):2366-75. PubMed ID: 21764819
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
[TBL] [Abstract][Full Text] [Related]
19. White matter microstructural integrity and cognitive function in a general elderly population.
Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
[TBL] [Abstract][Full Text] [Related]
20. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study.
Godin O; Tzourio C; Rouaud O; Zhu Y; Maillard P; Pasquier F; Crivello F; Alpérovitch A; Mazoyer B; Dufouil C
J Alzheimers Dis; 2010; 20(2):453-63. PubMed ID: 20164560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
